Chronic Bronchitis Treatment Market

Global Chronic Bronchitis Treatment Market Size, Share And Trend Analysis Report By Product Type (Antibiotics, Anti-inflammatory Drugs, Bronchodilator, Mucolytics), By End-User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025271 | Category : Pharmaceuticals | Delivery Format: /

The global chronic bronchitis treatment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor which is fuelling the growth of the global chronic bronchitis treatment market includes a large patient pool with COPD diseases. According to CDC (Centres for Disease Control and Prevention) in 2018, 9.0 million adults got diagnosed with chronic bronchitis. Moreover, there are a few more factors that are playing pivotal roles to fuel the bronchitis treatment market such as an increase in the geriatric population with increased prevalence of bronchitis, rise in habits like smoking and increased levels of chemical pollutants.  

Bronchitis is a respiratory disease that causes inflammation in the airways, also known as bronchi, of the lungs. It leads to irritation and inflammation of the lining of bronchial tubes, which are responsible for carrying air to and from the lungs.

The global chronic bronchitis treatment market analysis includes some of the key market players such as AstraZeneca plc., Novartis AG, GlaxoSmithKline plc., Dr Reddy's Laboratories Ltd., Sanofi S.A, and Boehringer Ingelheim International GmbH, among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: AstraZeneca plc., Novartis AG, GlaxoSmithKline plc., Dr. Reddy's Laboratories Ltd., Sanofi S.A, among others. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Chronic Bronchitis Treatment Market by Segment

By Product Type

Antibiotics

Anti-inflammatory Drugs

Bronchodilator

Mucolytics

By End-User

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Chronic Bronchitis Treatment Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World